why choose us

First received: May 22, 2023

Clinical Trial: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPG302 in Healthy Volunteers and ALS Participants

Study Status: Completed

Recruit Status: RECRUITING

Condition: Amyotrophic Lateral Sclerosis

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Randomized, Double Blind, Placebo Controlled, Single and Multiple Dose Escalation Study in Healthy Volunteers and an Expansion Cohort in Adult Participants With Amyotrophic Lateral Sclerosi

Brief Summary: The first-in-human Phase 1 study described herein will evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SPG302 in healthy volunteers and ALS participants

Read more